الفهرس 
AIM OF THE WORKOnly 14 pages are availabe for public view
 |  | from | 16 |  |  |
| | | from | 16 | | |
Abstract
Bladder cancer is the ninth most common cancer in the world, with
430,000 new cases diagnosed in 2012 and is the most often occurring cancer in
the urinary system. It has been reported that at the time of the diagnosis 30% of
bladder cancers are already muscle invasive for which the treatment includes
surgery and/or chemotherapy and/or radiation therapy.
Currently, radical cystectomy with lymph node dissection remains a gold
standard for local control of muscle invasive bladder cancer. It was
recommended for patients with muscle invasive bladder cancer T2-T4a, N0-Nx,
M0. Other indications include high-risk and recurrent superficial tumours,
BCG-resistant Tis, T1G3, as well as extensive papillary disease that cannot be
controlled with TUR and intravesical therapy alone.
The pathological stage at cystectomy and nodal status are predictors of
5 years survival .This procedure are described to be associated with various
complications. However, the reporting of these complications has not been
standardized and is usually divided into major and minor complications.
The aim of this study is to evaluate the perioperative complications in
patients with bladder cancer who underwent radical cystectomy and urinary
diversion (ileal conduit).
The study was done on 50 patients divided into 2 groups regarding to
postoperative complications using modified clavien classification;
1. Group 1: patients who have 65 years old or less.
2. Group 2: patients who have more than years old